Patent · US Expired

Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one

US5385726A · kind A · utility

7Cited by

3References

16Claims

0Family size

Assignee

Rhone-Poulenc Rorer Limited · DE

Inventors

Glenn S. Baldew · The Hague, NL
N. P. E. Vermeulen · Leiden, NL

Key dates

Filing date	Jul 12, 1993
Grant date	Jan 31, 1995
Priority date	—
Expiry date	Jul 12, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K33/243
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

2-Phenyl-1,2-benzisoselenazol-3(2H)-one(Ebselen) is capable of reducing the cisplatin-induced nephrotoxicity and neurotoxcity during cytostatic treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.